Amalgamated Bank Has $5.49 Million Holdings in Axon Enterprise, Inc. (NASDAQ:AXON)

Amalgamated Bank raised its position in shares of Axon Enterprise, Inc. (NASDAQ:AXONFree Report) by 6.6% during the third quarter, HoldingsChannel.com reports. The fund owned 27,564 shares of the biotechnology company’s stock after buying an additional 1,718 shares during the quarter. Amalgamated Bank’s holdings in Axon Enterprise were worth $5,485,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently made changes to their positions in AXON. CWM LLC raised its holdings in shares of Axon Enterprise by 1.8% in the 3rd quarter. CWM LLC now owns 2,669 shares of the biotechnology company’s stock worth $531,000 after acquiring an additional 46 shares during the last quarter. Mercer Global Advisors Inc. ADV raised its holdings in shares of Axon Enterprise by 2.4% in the 1st quarter. Mercer Global Advisors Inc. ADV now owns 2,499 shares of the biotechnology company’s stock worth $562,000 after acquiring an additional 59 shares during the last quarter. Signaturefd LLC raised its holdings in shares of Axon Enterprise by 16.1% in the 3rd quarter. Signaturefd LLC now owns 475 shares of the biotechnology company’s stock worth $95,000 after acquiring an additional 66 shares during the last quarter. O Shaughnessy Asset Management LLC raised its holdings in shares of Axon Enterprise by 5.4% in the 1st quarter. O Shaughnessy Asset Management LLC now owns 1,288 shares of the biotechnology company’s stock worth $290,000 after acquiring an additional 66 shares during the last quarter. Finally, Advisor Partners II LLC raised its holdings in shares of Axon Enterprise by 2.6% in the 4th quarter. Advisor Partners II LLC now owns 2,632 shares of the biotechnology company’s stock worth $437,000 after acquiring an additional 66 shares during the last quarter. Institutional investors own 76.52% of the company’s stock.

Axon Enterprise Trading Up 0.8 %

Shares of AXON stock opened at $259.46 on Wednesday. The company has a 50 day moving average of $249.67 and a 200-day moving average of $221.28. The company has a quick ratio of 2.78, a current ratio of 3.15 and a debt-to-equity ratio of 0.44. Axon Enterprise, Inc. has a 12-month low of $168.30 and a 12-month high of $262.95. The firm has a market cap of $19.44 billion, a P/E ratio of 133.06 and a beta of 0.90.

Axon Enterprise (NASDAQ:AXONGet Free Report) last released its quarterly earnings data on Tuesday, November 7th. The biotechnology company reported $0.71 EPS for the quarter, topping the consensus estimate of $0.40 by $0.31. The company had revenue of $413.60 million during the quarter, compared to the consensus estimate of $393.77 million. Axon Enterprise had a net margin of 9.96% and a return on equity of 12.63%. Sell-side analysts anticipate that Axon Enterprise, Inc. will post 2.29 earnings per share for the current year.

Analyst Upgrades and Downgrades

A number of equities research analysts recently weighed in on the stock. JMP Securities upped their target price on shares of Axon Enterprise from $250.00 to $285.00 and gave the stock a “market outperform” rating in a report on Tuesday. TheStreet upgraded shares of Axon Enterprise from a “c” rating to a “b” rating in a research note on Tuesday, November 7th. Raymond James increased their price objective on shares of Axon Enterprise from $223.00 to $233.00 and gave the company an “outperform” rating in a research note on Wednesday, November 8th. Needham & Company LLC reiterated a “buy” rating and issued a $240.00 price objective on shares of Axon Enterprise in a research note on Friday, February 2nd. Finally, Barclays increased their price objective on shares of Axon Enterprise from $247.00 to $296.00 and gave the company an “overweight” rating in a research note on Tuesday, January 2nd. Two research analysts have rated the stock with a hold rating and nine have issued a buy rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $255.36.

View Our Latest Analysis on AXON

Insider Buying and Selling

In other Axon Enterprise news, President Joshua Isner sold 260 shares of the firm’s stock in a transaction on Friday, December 1st. The shares were sold at an average price of $230.38, for a total value of $59,898.80. Following the completion of the transaction, the president now directly owns 356,229 shares of the company’s stock, valued at approximately $82,068,037.02. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. In other Axon Enterprise news, insider Jeffrey C. Kunins sold 41,167 shares of the firm’s stock in a transaction on Friday, November 10th. The shares were sold at an average price of $217.33, for a total value of $8,946,824.11. Following the completion of the transaction, the insider now directly owns 236,655 shares of the company’s stock, valued at approximately $51,432,231.15. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, President Joshua Isner sold 260 shares of the firm’s stock in a transaction on Friday, December 1st. The shares were sold at an average price of $230.38, for a total transaction of $59,898.80. Following the completion of the transaction, the president now directly owns 356,229 shares of the company’s stock, valued at $82,068,037.02. The disclosure for this sale can be found here. In the last ninety days, insiders sold 85,343 shares of company stock valued at $19,964,734. Company insiders own 6.10% of the company’s stock.

Axon Enterprise Profile

(Free Report)

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.

Featured Stories

Want to see what other hedge funds are holding AXON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axon Enterprise, Inc. (NASDAQ:AXONFree Report).

Institutional Ownership by Quarter for Axon Enterprise (NASDAQ:AXON)

Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.